RecruitingNCT05939232

Registry of X-linked Adrenoleukodystrophy


Sponsor

Beijing Tiantan Hospital

Enrollment

200 participants

Start Date

Jul 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.


Eligibility

Min Age: 6 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with x-linked adrenoleukodystrophy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Tiantan Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05939232


Related Trials